Generate a tailored SOP for Dr. Christiane Eberhardt. Improve your application with a focused, well-structured draft.
Christiane Eberhardt is a group leader at the Translational Research Centre Oncohaematology within the University of Geneva. Her research primarily focuses on vaccine immunology, specifically the understanding of vaccine-pathogen-specific adaptive immune responses in vulnerable populations and immunocompromised individuals. Eberhardt's work includes assessing the effects of antigenic priming and vaccination on T-cell responses, particularly in the context of COVID-19 vaccination for B-cell depleted patients. She aims to elucidate the influence of booster doses on T-cell receptor repertoire and functionality, alongside the role of antigen-presenting B cells in T-cell priming and memory generation. Eberhardt has contributed extensively to the understanding of antigen exposure duration and its impact on immune responses, leveraging human models and developing cellular tests for clinical use, especially in individuals with compromised immune systems. Her publications in notable journals emphasize her commitment to improving vaccine design and policies based on empirical evidence.
Includes Department of Management, Finance, Economics, and Statistics programs. GMAT is strongly encouraged but not mandatory for most GSEM masters.